Similarly, another study reported carriers of cyclin D1 G870A and G1722C polymorphisms, especially among smokers, were characterized by increased risk for developing HNSCC (Lin et al., 2014), which is another paradigm of a site-specific prevalence regarding cyclin D1 oncogene transformation. The gene discussed is CCND1; the disease is head and neck squamous cell carcinoma.